Efficacy of mesenchymal stem cell enriched grafts in an ovine posterolateral lumbar spine model

被引:61
作者
Gupta, Munish C.
Theerajunyaporn, Thongchai
Maitra, Sukanta
Schmidt, Mary Beth
Holy, Chantal E.
Kadiyala, Sudha
Bruder, Scott P.
机构
[1] Univ Calif Davis, Dept Orthoped, Sacramento, CA 95817 USA
[2] DePuy Biol, Raynham, MA USA
关键词
osteoprogenitors; bone marrow; bone graft; spine fusion model; tricalcium phosphate;
D O I
10.1097/01.brs.0000258863.40984.32
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. Four groups of 6 animals underwent single-level noninstrumented posterolateral lumbar fusion (PLF) with one of the following grafts: 1) autograft, 2) cell-enriched beta-tricalcium phosphate (TCP), 3) TCP with whole bone marrow, and 4) TCP alone. Plain radiographs were taken after surgery and at death, 6 months after surgery. Explanted spine segments were analyzed by manual palpation, micro-CT, and histology. Objective. A sheep spine fusion study was undertaken to evaluate the healing performance of a TCP graft enriched with osteoprogenitor cells using Selective Cell Retention technology (SCR), compared with autograft, TCP with whole bone marrow, and TCP alone. Summary of Background Data. Improved bone healing with previously demonstrated using grafts enriched in osteoprogenitor cells. Methods. Cell-enriched grafts were obtained by processing 30 mL of bone marrow through 10 mL of TCP. TCP was also used either saturated with bone marrow or alone. Results. At 6 months, 33% of the SCR-enriched TCP and 25% of the autograft sites were fused, compared with 8% of the TCP plus whole bone marrow and 0% of the TCP alone. Histology of fused samples showed denser bone formation in the SCR-enriched TCP grafts than in the autograft sites. Conclusions. The use of SCR- enriched TCP and autograft resulted in similar fusion rates in an ovine posterolateral noninstrumented lumbar spine fusion model.
引用
收藏
页码:720 / 726
页数:7
相关论文
共 28 条
[1]  
Bauer TW., 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
[2]   Clinical indications of calcium-phosphate biomaterials and related composites for orthopedic procedures [J].
Block, JE ;
Thorn, MR .
CALCIFIED TISSUE INTERNATIONAL, 2000, 66 (03) :234-238
[3]  
Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
[4]  
Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
[5]  
BURWELL RG, 1985, CLIN ORTHOP RELAT R, V200, P125
[6]   DEVELOPMENT OF AN OSTEOGENIC BONE-MARROW PREPARATION [J].
CONNOLLY, J ;
GUSE, R ;
LIPPIELLO, L ;
DEHNE, R .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1989, 71A (05) :684-691
[7]   Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis [J].
Connolly, JF .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1998, (355) :S257-S266
[8]  
Cornell CN, 1998, CLIN ORTHOP S, V355, P267
[9]  
EDWARDS SL, 2003, ISSLS, P117
[10]   CHRONIC DONOR SITE PAIN COMPLICATING BONE-GRAFT HARVESTING FROM THE POSTERIOR ILIAC CREST FOR SPINAL-FUSION [J].
FERNYHOUGH, JC ;
SCHIMANDLE, JJ ;
WEIGEL, MC ;
EDWARDS, CC ;
LEVINE, AM .
SPINE, 1992, 17 (12) :1474-1480